Geriatric Nursing
Volume 27, Issue 3 , Pages 142-148 , May 2006

Management of Lipid Disorders

References 

  1. American Heart Association. Heart Disease and Stroke Statistics – 2005 update. Dallas, Texas, American Heart Association; 2005. Available at: http://www.americanheart.org/presenter.jhtml?identifier=1200026 Accessed on July 26, 2005.
  2. Gluckman TJ , Baranowski B , Ashen D , Henrikson CA , et al.   A practical and evidence-based approach to cardiovascular disease risk reduction . Arch Intern Med . 2004;164:1490–1500
  3. Ko DT , Mamdani M , Alter DA . Lipid-lowering therapy with statins in high-risk elderly patients (the treatment risk paradox) . JAMA . 2004;291:1864–1870
  4. Grundy SM , Cleeman JI , Merz NB , Brewer B , et al.   Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines . Circulation . 2004;110:227–239
  5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults . JAMA . 2001;285:2486–2497
  6. Pyorala K , et al.   Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary artery disease (A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)) . Diabetes Care . 1997;20:614–620
  7. Shepherd J , Blauw GJ , Murphy MB , et al.   Pravastatin in elderly individuals at risk of vascular disease (PROSPER) (a randomized controlled trial) . Lancet . 2002;360(9346):1623–1630
  8. Heart Protection Study Collaborate Group . MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals (a randomised placebo-controlled trial) . Lancet . 2002;360(9326):7–22
  9. Collins R , et al.   MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes (a randomized placebo-controlled trial) . Lancet . 2003;361:2005–2016
  10. Sever PS , Dahlof B , Poulter NR , Wedel H , et al.  ASCOT investigators   Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandanavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA) (a multicentre randomized controlled trial) . Lancet . 2003;361:1149–1158
  11. Goldberg RB , et al.   Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels (subgroup analyses in the cholesterol and recurrent events (CARE) trial) . Circulation . 1998;98:2513–2519
  12. Sacks FM , et al.   Coronary heart disease in patients with low LDL-cholesterol benefit of pravastatin in diabetes and enhanced role for HDL-cholesterol and triglycerides as risk factors . Circulation . 2002;105:1424–1428
  13. Lewis SJ , Sacks FM , Mitchell JS , et al.   Effect of pravastatin on cardiovascular events in women after myocardial infarction (The Cholesterol and Recurrent Events (CARE) Trial) . J Am Coll Cardiol . 1998;32:140–146
  14. Lewis SJ , Moye LA , Sacks FM , et al.   Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range (Results of the Cholesterol and Recurrent Events (CARE) Trial) . Ann Intern Med . 1998;129:681–689
  15. Plehn JF , Davis BR , Sacks FM , et al.   Reduction of stroke incidence after myocardial infarction with pravastatin (The Cholesterol and Recurrent Events (CARE) Study) . Circulation . 1999;99:216–223
  16. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) . Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report . Circulation . 2002;106:3143–3421
  17. Aronow WS , Ahn C . Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statins versus no lipid-lowering drug . Am J Cardiol . 2002;89:67–69
  18. Aronow WS , Ahn C , Gutstein H . Reduction of new coronary events and new atherothrombotic brain infarction in older persons with diabetes mellitus, prior myocardial infarction, and serum low-density lipoprotein cholesterol ≥125 mg/dL treated with statin . J Gerontol Series A Biol Sci Med Sci . 2002;57:M747–M750

PII: S0197-4572(06)00121-2

doi: 10.1016/j.gerinurse.2006.03.002

Geriatric Nursing
Volume 27, Issue 3 , Pages 142-148 , May 2006

Article Tools

* Image Usage & Resolution